Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kidney Transplantation
Clinical trial NCT05511779 · TERMINATED
Trial details
- NCT number
- NCT05511779
- Sponsor
- SymBio Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-14
- Primary completion
- 2023-04-13
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.